Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling:: theophylline and midazolam as model drugs

被引:171
作者
Björkman, S
机构
[1] Malmo Univ Hosp, Hosp Pharm, SE-20502 Malmo, Sweden
[2] Uppsala Univ, Dept Pharmaceut Biosci, Div Pharmacokinet & Drug Therapy, Uppsala, Sweden
关键词
body composition; children; infants; midazolam; pharmacokinetics; theophylline; tissue distribution;
D O I
10.1111/j.1365-2125.2004.02225.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To create a general physiologically based pharmacokinetic (PBPK) model for drug disposition in infants and children, covering the age range from birth to adulthood, and to evaluate it with theophylline and midazolam as model drugs. Methods Physiological data for neonates, 0.5-, 1-, 2-, 5-, 10- and 15-year-old children, and adults, of both sexes were compiled from the literature. The data comprised body weight and surface area, organ weights, vascular and interstitial spaces, extracellular body water, organ blood flows, cardiac output and glomerular filtration rate. Tissue: plasma partition coefficients were calculated from rat data and unbound fraction (f(u)) of the drug in human plasma, and age-related changes in unbound intrinsic hepatic clearance were estimated from CYP1A2 and CYP2E1 (theophylline) and CYP3A4 (midazolam) activities in vitro. Volume of distribution (V-dss), total and renal clearance (CL and CLR) and elimination half-life (t(1/2)) were estimated by PBPK modelling, as functions of age, and compared with literature data. Results The predicted V-dss of theophylline was 0.4-0.6 l kg(-1) and showed only a modest change with age. The median prediction error (MPE) compared with literature data was 3.4%. Predicted total CL demonstrated the time-course generally reported in the literature. It was 20 ml h(-1) kg(-1) in the neonate, rising to 73 ml h(-1) kg(-1) at 5 years and then decreasing to 48 ml h(-1) kg(-1) in the adult. Overall, the MPE was - 4.0%. Predicted t(1/2) was 18 h in the neonate, dropping rapidly to 4.6-7.2 h from 6 months onwards, and the MPE was 24%. The predictions for midazolam were also in good agreement with literature data. V-dss ranged between 1.0 and 1.7 l kg(-1) and showed only modest change with age. CL was 124 ml h(-1) kg(-1) in the neonate and peaked at 664 ml h(-1) kg(-1) at 5 years before decreasing to 425 ml h(-1) kg(-1) in the adult. Predicted t(1/2) was 6.9 h in the neonate and attained 'adult' values of 2.5-3.5 h from 1 year onwards. Conclusions A general PBPK model for the prediction of drug disposition over the age range neonate to young adult is presented. A reference source of physiological data was compiled and validated as far as possible. Since studies of pharmacokinetics in children present obvious practical and ethical difficulties, one aim of the work was to utilize maximally already available data. Prediction of the disposition of theophylline and midazolam, two model drugs with dissimilar physicochemical and pharmacokinetic characteristics, yielded results that generally tallied with literature data. Future use of the model may demonstrate further its strengths and weaknesses.
引用
收藏
页码:691 / 704
页数:14
相关论文
共 65 条
[1]   DEPENDENCE OF THE RENAL EXCRETION OF THEOPHYLLINE ON ITS PLASMA-CONCENTRATIONS AND URINE FLOW-RATE IN ASTHMATIC-CHILDREN [J].
AGBABA, D ;
POKRAJAC, M ;
VARAGIC, VM ;
PESIC, V .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (12) :827-830
[2]  
Alcorn J, 2002, CLIN PHARMACOKINET, V41, P1077, DOI 10.2165/00003088-200241130-00005
[3]   Ontogeny of hepatic and renal systemic clearance pathways in infants - Part I [J].
Alcorn, J ;
McNamara, PJ .
CLINICAL PHARMACOKINETICS, 2002, 41 (12) :959-998
[4]   PHARMACOKINETICS OF DIURETICS AND METHYLXANTHINES IN THE NEONATE [J].
ARANDA, JV ;
TURMEN, T ;
SASYNIUK, BI .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (01) :55-63
[5]   A COMPARISON OF THE PHARMACOKINETICS OF THEOPHYLLINE IN ASTHMATIC-CHILDREN IN THE ACUTE EPISODE AND IN REMISSION [J].
ARNOLD, JD ;
HILL, GN ;
SANSOM, LN .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (06) :443-447
[6]   Dose estimation for children [J].
Baber, N ;
Pritchard, D .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (05) :489-493
[7]  
BAKER GL, 1969, AM J CLIN NUTR, V22, P829
[8]  
Behrman RE, 2000, TXB PEDIAT
[9]   Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model [J].
Björkman, S ;
Wada, DR ;
Berling, BM ;
Benoni, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (09) :1226-1241
[10]   INTERSPECIES VARIATION IN LIVER WEIGHT, HEPATIC BLOOD-FLOW, AND ANTIPYRINE INTRINSIC CLEARANCE - EXTRAPOLATION OF DATA TO BENZODIAZEPINES AND PHENYTOIN [J].
BOXENBAUM, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (02) :165-176